Daniel R. George, Ph.D., M.Sc. on April 15, 2022
The Alzheimer's Association's advocacy for a flawed drug showed clouded judgment; it must return to core values of prevention, care, and inclusion.
The Alzheimer's Association's advocacy for a flawed drug showed clouded judgment; it must return to core values of prevention, care, and inclusion.